Diffuse Metabolic Abnormalities in Reversible Posterior Leukoencephalopathy Syndrome

References

1. ↵
   Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500

   CrossRefPubMedWeb of Science
2. ↵
   Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199–1206

   Abstract/FREE Full Text
3. ↵
   Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999;14:277–281

   Abstract/FREE Full Text
4. ↵
   Delanty N, Vaughan C, Frucht S, Stubgen P. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997;49:686–689

   Abstract/FREE Full Text
5. ↵
   Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998;19:415–417

   Abstract
6. ↵
   Kupferschmidt H, Bont A, Schnorf H, et al. Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med 1995;123:598–600

   PubMedWeb of Science
7. ↵
   van Zijl PC, Barker PB. Magnetic resonance spectroscopy and spectroscopic imaging for the study of brain metabolism. In: Lester DS, Felder CC, Lewis EN, eds. Imaging Brain Structure and Function. New York: New York Academy of Science;1997 :75–96
8. ↵
   Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361–364

   CrossRefPubMedWeb of Science
9. ↵
   Pavlakis SG, Frank Y, Kalina P, Chandra M, Lu D. Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol 1997;16:145–148

   CrossRefPubMedWeb of Science
10. ↵
    Russell MT, Nassif AS, Cacayorin ED, Awwad E, Perman W, Dunphy F. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging 2001;19:129–132

    CrossRefPubMedWeb of Science
11. ↵
    Sengar AR, Gupta RK, Dhanuka AK, Roy R, Das K. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485–1490

    Abstract
12. ↵
    Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277–282

    PubMedWeb of Science
13. ↵
    Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton spectroscopic imaging of the human brain. Magn Reson Med 1996;35:356–363

    PubMedWeb of Science
14. ↵
    Barker PB, Szopinski K, Horska A. Metabolic heterogeneity at the level of the anterior and posterior commissures. Magn Reson Med 2000;43:348–354

    CrossRefPubMed
15. ↵
    Casey S. “T2 washout”: an explanation for normal diffusion-weighted images despite abnormal apparent diffusion coefficient maps. AJNR Am J Neuroradiol 2001;22:1450–1451

    FREE Full Text
16. ↵
    Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369–1376

    Abstract/FREE Full Text
17. ↵
    Port JD, Beauchamp NJ Jr. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 1998;18:353–367

    PubMedWeb of Science
18. ↵
    Horn EH, Filshie M, Kerslake RW, Jaspan T, Worthington BS, Rubin PC. Widespread cerebral ischaemia treated with nimodipine in a patient with eclampsia. BMJ 1990;301:794
19. Ito T, Sakai T, Inagawa S, Utsu M, Bun T. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995;16:1344–1346

    Abstract
20. Lewis LK, Hinshaw DB Jr, Will AD, Hasso AN, Thompson JR. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988;30:59–64

    CrossRefPubMedWeb of Science
21. ↵
    Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326–329

    Abstract/FREE Full Text
22. ↵
    Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 1988;45:1078–1083

    CrossRefPubMedWeb of Science
23. ↵
    Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756–765

    CrossRefPubMedWeb of Science
24. ↵
    Provenzale JM, Petrella JR, Cruz LC Jr, Wong JC, Engelter S, Barboriak DP. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001;22:1455–1461

    Abstract/FREE Full Text
25. ↵
    Dillon WP, Rowley H. The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol 1998;19:591

    PubMedWeb of Science
26. ↵
    Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–1627

    Abstract/FREE Full Text
27. ↵
    Brenner RE, Munro PM, Williams SC, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737–745

    PubMedWeb of Science
28. ↵
    Lindheimer MD, Roberts JM, Cunningham FG. Chesley’s Hypertensive Disorders in Pregnancy. New York: McGraw Hill;1999
29. ↵
    Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–989

    Abstract
30. ↵
    van der Knaap MS, Valk J. Leukoencephalopathy after chemotherapy and/or radiation. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. Berlin: Springer-Verlag;1995 :406–411
31. ↵
    MacGillivray I. Pre-Eclampsia: The Hypertensive Disease of Pregnancy. Philadelphia: W.B Saunders Co.;1983
32. ↵
    Barker PB. N-Acetylaspartate: a neuronal marker? Ann Neurol 2001;49:423–424

    CrossRefPubMedWeb of Science